These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8585070)

  • 1. [Present state of preclinical research on the efficacy and safety of para immunity inducers from poxviruses. A study of the literature].
    Mayr B; Mayr A
    Tierarztl Prax; 1995 Dec; 23(6):542-52. PubMed ID: 8585070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of of non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine].
    Mayr A
    Berl Munch Tierarztl Wochenschr; 2001; 114(5-6):184-7. PubMed ID: 11413711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a non-immunising, paraspecific vaccine from attenuated pox viruses: a new type of vaccine.
    Mayr A
    New Microbiol; 2003 Jan; 26(1):7-12. PubMed ID: 12578306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental detection of the paraspecific effects of purified and inactivated poxviruses].
    Mayr A; Büttner M; Wolf G; Meyer H; Czerny C
    Zentralbl Veterinarmed B; 1989 Mar; 36(2):81-99. PubMed ID: 2473583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The paraspecific immune defense: possibilities and limits].
    Mayr A
    Tierarztl Prax; 1993 Feb; 21(1):1-9. PubMed ID: 8470097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive protection of sheep against capripoxvirus.
    Kitching RP
    Res Vet Sci; 1986 Sep; 41(2):247-50. PubMed ID: 3022361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a commercial quail pox vaccine (Bio-Pox Q) for the control of "variant" fowl poxvirus infections.
    Fatunmbi OO; Reed WM
    Avian Dis; 1996; 40(4):792-7. PubMed ID: 8980808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimentation, in wool-producing sheep, on the innocuity and efficacy of a modified poxvirus, isolated from a Mauritanian sheep with nodular sheep pox].
    Gilbert Y; Saurat P; Chantal J; Chamoiseau G
    Rev Elev Med Vet Pays Trop; 1985; 38(1):22-7. PubMed ID: 3018872
    [No Abstract]   [Full Text] [Related]  

  • 9. Taking advantage of the positive side-effects of smallpox vaccination.
    Mayr A
    J Vet Med B Infect Dis Vet Public Health; 2004 Jun; 51(5):199-201. PubMed ID: 15330977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'supervirus'? Lessons from IL-4-expressing poxviruses.
    Stanford MM; McFadden G
    Trends Immunol; 2005 Jun; 26(6):339-45. PubMed ID: 15922951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunization of pigs against swine pox with culture-adapted virus].
    Kubin G
    Wien Tierarztl Monatsschr; 1972 Oct; 59(10):317-9. PubMed ID: 4345889
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis.
    Horohov DW; Breathnach CC; Sturgill TL; Rashid C; Stiltner JL; Strong D; Nieman N; Holland RE
    Equine Vet J; 2008 Jul; 40(5):468-72. PubMed ID: 18678554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulating the local tumor microenvironment with poxviruses expressing costimulatory molecules.
    Kaufman HL
    Ann N Y Acad Sci; 2005 Dec; 1062():41-50. PubMed ID: 16461787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of paramunization in raising pigs].
    Mayr A
    Tierarztl Prax; 1986; 14(2):237-44. PubMed ID: 3738897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for lumpy skin disease, sheep pox and goat pox.
    Kitching RP
    Dev Biol (Basel); 2003; 114():161-7. PubMed ID: 14677686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of paramunization. Option and limits in veterinary medicine.
    Büttner M
    Comp Immunol Microbiol Infect Dis; 1993 Jan; 16(1):1-10. PubMed ID: 8440082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response in buffalo calves experimentally infected with buffalo-pox virus.
    Rana UV; Garg SK; Chandra R; Rao VD; Singh IP
    J Commun Dis; 1986 Sep; 18(3):193-7. PubMed ID: 3033055
    [No Abstract]   [Full Text] [Related]  

  • 19. Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections.
    Müllbacher A; Wallich R; Moyer RW; Simon MM
    J Immunol; 1999 Jun; 162(12):7315-21. PubMed ID: 10358181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.